Сlinical and laboratory characteristics of infectious mononucleosis caused by Epstein-Barr, effectiveness of treatment methods
| dc.contributor.author | Yurko, Kateryna | |
| dc.contributor.author | Kozko, Volodymyr | |
| dc.contributor.author | Merkulova, Nina | |
| dc.contributor.author | Моhylenets, Olena | |
| dc.contributor.author | Khrystenko, Nadia | |
| dc.date.accessioned | 2020-12-08T08:56:40Z | |
| dc.date.available | 2020-12-08T08:56:40Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | The efficacy of combined use of Valacyclovir and Nuclex in complex therapy of patients with infectious mononucleosis caused by Epstein - Barr virus (EBV) was studied. The use of such therapy was found to promotes regression of clinical symptoms, contribute to normalization of indices of clinical blood tests and lead to a decrease of the number of EVB's DNA copies in the blood serum or complete elimination of virus. | en_US |
| dc.identifier.citation | Сlinical and laboratory characteristics of infectious mononucleosis caused by Epstein-Barr, effectiveness of treatment methods / K. Yurko, V. Kozko, N. Merkulova, O. Моhylenets, N. Khrystenko // Norwegian Journal of Development of the International Science. – 2020. – N 39. – P. 50–52. | en_US |
| dc.identifier.issn | 3453-9875 | |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/27872 | |
| dc.language.iso | en_US | en_US |
| dc.subject | infectious mononucleosis | en_US |
| dc.subject | therapy | en_US |
| dc.subject | clinical picture | en_US |
| dc.subject | Epstein-Barr virus | en_US |
| dc.subject | diagnosis | en_US |
| dc.title | Сlinical and laboratory characteristics of infectious mononucleosis caused by Epstein-Barr, effectiveness of treatment methods | en_US |
| dc.type | Article | en_US |